QUOTE
AstraZeneca PLC (ADR) (AZN)
$
47.90
 $0.14 (0.29%) Jan 26
|
15 Stanhope Gate
,
London,
W1K 1LN
,
GBR
+44-20-73045000
http://www.astrazeneca.com/ |
|
|
| PRICES |
| Open |
Volume |
| 47.66 |
968,500 |
| High |
Low |
| 48.13 |
47.48 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 67431 |
755,200 |
| 52wk High |
52wk Low |
| 52.40 |
40.95 |
|
| RATIOS |
| P/E |
EPS |
| n/a |
n/a |
| BV |
P/BV |
| 16.49 |
2.90 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| 2.70 |
5.64% |
| Shares |
Inst Owner |
| 1407.74 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
| Income statement |
| Total Revenue |
$18,849 | $21,426 | $23,950 | $26,475 | $29,559 | $31,601 | $32,804 | $33,269 |
| Operating Income |
$4,007 | $4,547 | $6,502 | $8,216 | $8,094 | $9,144 | $11,543 | $11,494 |
| Net Income |
$2,149 | $2,951 | $3,884 | $4,392 | $5,595 | $6,101 | $7,521 | $8,053 |
| Balance Sheet |
| Total Assets |
$23,561 | $25,652 | $24,840 | $29,932 | $47,957 | $46,784 | $54,920 | $56,127 |
| Total Equity |
$13,086 | $14,404 | $13,597 | $15,304 | $14,778 | $15,912 | $20,660 | $23,213 |
| Total Liabilities |
$10,475 | $11,248 | $11,243 | $14,628 | $33,179 | $30,872 | $34,260 | $32,914 |
| Cash Flow |
| Operating |
$3,368 | $4,817 | $6,743 | $7,693 | $7,510 | $8,742 | $11,739 | $10,680 |
| Investing |
$-852 | $970 | $-1,182 | $-272 | $-14,887 | $-3,896 | $-2,476 | $-2,340 |
| Financing |
$-2,674 | $-2,761 | $-4,572 | $-5,366 | $6,051 | $-6,362 | $-3,629 | $-7,220 |
| Net Cash Change |
$-96 | $3,055 | $968 | $2,094 | $-1,262 | $-1,604 | $5,705 | $1,153 |
|
Earning Call Calender
|
| 2010 | 2009 |
2008 |
2007 |
2006 |
28 October 2010
|
29 January 2009
30 April 2009
30 July 2009
29 October 2009
|
31 January 2008
24 April 2008
31 July 2008
30 October 2008
|
01 February 2007
23 April 2007
26 April 2007
26 July 2007
01 November 2007
|
02 February 2006
27 April 2006
27 July 2006
| |
|
| Earning Call Summary |
Transcripts |
| |
|
Management
|
|
Executive |
Title |
|
David R. Brennan |
Chief Executive Officer, Director | |
|
David Mott |
President and Chief Executive Officer of MedImmune |
|
Simon Lowth |
Chief Financial Officer, Executive Director |
|
John Patterson |
Executive Director-Development |
|
Lynn Tetrault |
Executive Vice President Human Resources and Corporate Affairs |
|
Tony Zook |
Executive Vice President - Global Marketing and President and Chief Executive Officer, North America |
|
David Smith |
Executive Vice President of Operations |
|
Bruno Angelici |
Executive Vice President, Europe, Japan, Asia Pacifi c and Rest of the World |
|
Jan Lundberg |
Executive Vice-President, Discovery Research |
|
|
|
